Particularly in NF1-associated MPNST, it is generally accepted that alterations in NF1, CDKN2A, TP53, and SUZ12 are involved in tumor progression from benign to malignant tumors. Here, CDKN2A is linked to malignant peripheral nerve sheath tumor.